Visualizing Microvascular Remodeling for Precise Staging of Inflammatory Bowel Disease via Ultralow-Dose Magnetic Resonance Enterography
Abstract Accurate staging of inflammatory bowel disease (IBD) using magnetic resonance enterography (MRE) remains challenging because of limited precision. Although microvascular remodeling is a pivotal driver of IBD progression, its contribution to imaging-based activity assessment remains insufficiently characterized owing to the rapid extravasation and short intravascular residence of current contrast agents. Here, an ultralow-dose MRE strategy is developed using a long-circulating (half-life ≈ 5 h), high-relaxivity (r1 = 40.89 mM–1 s–1 at 3.0 T) ultrasensitive nanoprobe to enable direct visualization and quantitative characterization of intestinal microvascular remodeling in vivo. In a rat colitis model, this approach reveals dynamic microvascular alterations during inflammatory progression and generates enhancement patterns that reflect both vascular retention and permeability-associated changes. Quantitative analysis of vascular imaging features enabled the development of a microvascular feature index (MFI), which was significantly associated with histopathological inflammatory activity. Integration of MFI with conventional MR metrics improved disease activity stratification by distinguishing low-activity lesions from moderate-to-severe inflammatory activity. This work establishes inflammation-associated vascular remodeling as an imaging-accessible biological process and demonstrates that contrast kinetics engineering can enable its quantitative characterization as an imaging biomarker. The resulting microvascular-centered framework complements conventional MRE and provides a biologically informed approach for inflammatory activity assessment in IBD.
Authors
- 向科
- Xi Wei (ORCID: https://orcid.org/0000-0003-4734-3900)
- Gang Shu (ORCID: https://orcid.org/0000-0002-3769-0012)
- Jinbin Pan (ORCID: https://orcid.org/0000-0002-8398-760X)
- Shao‐Kai Sun (ORCID: https://orcid.org/0000-0001-6136-9969)
- Cai Zhang (ORCID: https://orcid.org/0000-0001-9004-2543)
- Junzi Zhou
- Wenjing Hou
Institutions
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- ACS Nano
- Published
- 2026-09-04
- DOI
- https://doi.org/10.1021/acsnano.6c05323
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City